NCT06555718

Brief Summary

The main advantage of patient-to-patient peer counseling is that it benefits both the client and the peer mentors as real and authentic experiences are shared. Since both individuals go through similar experiences, they can share common feelings. Although there are studies in the literature showing the effectiveness of peer support groups in different patient groups, studies on chronic kidney disease patients are limited. There are no studies on the effects of these programs on caregivers. This study will be conducted to examine the effects of peer support program applied to chronic kidney patients on patient outcomes and caregivers.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 11, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 26, 2024

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

July 30, 2024

Completed
16 days until next milestone

First Posted

Study publicly available on registry

August 15, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2025

Completed
Last Updated

August 15, 2024

Status Verified

August 1, 2024

Enrollment Period

7 months

First QC Date

July 30, 2024

Last Update Submit

August 13, 2024

Conditions

Keywords

Peer sportnursinghemodialysis

Outcome Measures

Primary Outcomes (1)

  • Adaptation to the disease.

    "End Stage Renal Disease Adaptation Questionnaire (ESRD-AQ)" Total score varies between 0 and 1200. As the score obtained from the scale increases, the level of treatment compliance increases.

    The scale will be completed before the intervention and at 3, 7 and 9 weeks.

Secondary Outcomes (1)

  • Self-Care

    The scale will be completed before the intervention and at 3, 7 and 9 weeks.

Other Outcomes (2)

  • Patient outcomes

    The Kt/V value of all patients calculated before the intervention and the change in the value measured 3, 7 and 9 weeks after the intervention will be completed by the researcher.

  • Caregivers on Care Burden

    The scale will be completed by the patients before the intervention and at 9th week.

Study Arms (2)

Intervention group (Peer support)

OTHER

"Peer mentors" will be determined among the participant patients in accordance with the peer mentor guide selection criteria. The determined peer mentors will participate in the "Peer Mentor Training Programme". Implementation of the research; Peer support programme for the intervention group will be carried out for 10 weeks in accordance with the peer guide-client implementation plan Standard follow-up and training programme will be applied to the control group in accordance with the procedures of the institution. The data collection forms used in the research process will be collected at the stages specified in the study flow plan and data entry will be made by the researcher.

Behavioral: The Peer Support Program

Control group (Standart care)

OTHER

No intervention will be made by the researcher to the control group. The standard care of the institution will be applied to the patients.

Behavioral: Standart care

Interventions

Implementation of the research; Peer support programme for the intervention group will be carried out for 10 weeks in accordance with the peer guide-client implementation plan. Standard follow-up and training programme will be applied to the control group in accordance with the procedures of the institution.

Intervention group (Peer support)
Standart careBEHAVIORAL

The standard care provided by the institution will continue.

Control group (Standart care)

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Speaking Turkish
  • To be literate
  • CKD receiving haemodialysis
  • Volunteering
  • years of age or older
  • Being open to communication and co-operation
  • Not having any psychiatric disorder
  • Speaking Turkish
  • To be literate
  • CKD receiving haemodialysis
  • Volunteering
  • years of age or older
  • Not having any psychiatric disorder
  • Being under 18 years of age
  • Speaking a language other than Turkish
  • +6 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Canan Yüksel Acar

Istanbul, 34752, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Health Behavior

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Canan Yüksel Acar, Msc

    Acibadem Universty

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Intervation group (Peer support) Control group (Standart care)
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The study will start after obtaining official institutional permissions. The researcher will examine the profile of patients receiving treatment at the dialysis center. After this stage, the following steps will be followed
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 30, 2024

First Posted

August 15, 2024

Study Start

January 11, 2024

Primary Completion

July 26, 2024

Study Completion

January 30, 2025

Last Updated

August 15, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations